Having raised $250 million for its third India healthcare fund, Invascent Capital plans to take advantage of a greater willingness among entrepreneurs to work with financial investors
Hari Buggana, a managing director of Invascent Capital, sees the firm’s investment last year in Indian pharmaceutical developer Symbiotec alongside Motilal Oswal Private Equity as a sign of things to...
Investors see opportunity in bringing a promising currency exchange-focused fintech model from Europe into Southeast Asia. Singapore-focused YouTrip is the region’s first mover in this niche
Traditionally the overlooked, underappreciated or misrepresented facet of ESG, governance is gaining prominence in emerging markets private equity as investors reassess risk exposure
Capital has poured into China’s online education sector in recent years, but with losses mounting and valuations called into question, investors are finding that not all business models are created equal
Endiya Partners, an early-stage VC investor based in India, has achieved a first close of $40 million for its second fund. The target is $70 million.